The Associated Press @AP
U.S. health officials have approved a closely watched Alzheimer’s drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh. https://t.co/dLgdkn7x2p — PolitiTweet.org